Show simple item record

dc.contributor.authorKousiappa, Ioannaen
dc.contributor.authorvan de Vijver, D. A.en
dc.contributor.authorDemetriades, Ioannisen
dc.contributor.authorKostrikis, Leontios G.en
dc.creatorKousiappa, Ioannaen
dc.creatorvan de Vijver, D. A.en
dc.creatorDemetriades, Ioannisen
dc.creatorKostrikis, Leontios G.en
dc.date.accessioned2019-11-04T12:52:15Z
dc.date.available2019-11-04T12:52:15Z
dc.date.issued2009
dc.identifier.issn1931-8405
dc.identifier.urihttp://gnosis.library.ucy.ac.cy/handle/7/53212
dc.description.abstractAbstract The molecular epidemiology of HIV-1 infection was first studied in Cyprus in the mid-1990s, but the extent of HIV-1 diversity and the prevalence of drug resistance have remained elusive. In an effort to address this issue, the present study examined HIV-1 strains isolated from 37 newly diagnosed untreated HIV-1 patients, representing 72% of the total number of newly diagnosed and drug-naive patients in the period 2003 to 2006. DNA sequences encoding the gag (p17, p24, p2, p7, p1, and p6), pol (protease and reverse transcriptase), and env (gp160) regions were amplified by RT-PCR from plasma HIV-1 RNA from all patients and sequenced using a newly designed methodology. All amplified products were studied according to established genetic methodologies to determine the genetic subtype and the prevalence of drug-resistance-associated mutations to currently available antiretroviral drugs. Analyses of the obtained viral sequences indicated that subtype A was the most common subtype present and accounted for 38% of the infections followed by subtype B (35%), subtype C (13%), CRF02_AG (8%), and subtypes D and CRF01_AE (3% each). One patient (2.7%) had an M41L/M and another patient (2.7%) an M184V amino acid substitution in the reverse transcriptase (RT) associated with high-level resistance to RT inhibitors. There were no patients with resistant mutations to protease inhibitors (PI). Additionally, one patient (2.7%) had an L44M amino acid substitution within the HR1 region of gp41 conferring resistance to the enfuvirtide (T20) fusion inhibitor. Similar to results of the 1994 molecular epidemiological study, these data demonstrate the extensive heterogeneity of HIV-1 infection in Cyprus and the low prevalence of transmitted resistance to current HIV-1 antiretroviral drugs. Taken together, these findings demonstrate that HIV-1 infection in Cyprus is being replenished by a continuous influx of new strains from many countries, establishing an ever-evolving and polyphyletic infection in the island.en
dc.sourceAIDS Research and Human Retrovirusesen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-60549105805&partnerID=40&md5=909bfd1379748971bfb150a164cc562b
dc.subjectCyprusen
dc.subjectarticleen
dc.subjecthumanen
dc.subjectHumansen
dc.subjectadulten
dc.subjectfemaleen
dc.subjectdrug effecten
dc.subjectHuman immunodeficiency virus infectionen
dc.subjectmaleen
dc.subjectgenotypeen
dc.subjectgenetic polymorphismen
dc.subjectepidemiologyen
dc.subjectHIV Infectionsen
dc.subjectmiddle ageden
dc.subjectmolecular geneticsen
dc.subjectAnimalsen
dc.subjectanimalen
dc.subjectgeneticsen
dc.subjectMolecular Sequence Dataen
dc.subjectclassificationen
dc.subjectreverse transcription polymerase chain reactionen
dc.subjectViral Proteinsen
dc.subjectvirologyen
dc.subjectvirus proteinen
dc.subjectphylogenyen
dc.subjectHuman immunodeficiency virus 1en
dc.subjectHIV-1en
dc.subjectReverse Transcriptase Polymerase Chain Reactionen
dc.subjectantiviral resistanceen
dc.subjectisolation and purificationen
dc.subjectDNA sequenceen
dc.subjectcluster analysisen
dc.subjectPolymorphism, Geneticen
dc.subjectsequence homologyen
dc.subjectEpidemiology, Molecularen
dc.subjectDrug Resistance, Viralen
dc.subjectSequence Analysis, DNAen
dc.subjectamino acid substitutionen
dc.subjectmissense mutationen
dc.subjectMutation, Missenseen
dc.titleGenetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.en
dc.typeinfo:eu-repo/semantics/article
dc.description.volume25
dc.description.startingpage23
dc.description.endingpage35
dc.author.facultyΣχολή Θετικών και Εφαρμοσμένων Επιστημών / Faculty of Pure and Applied Sciences
dc.author.departmentΤμήμα Βιολογικών Επιστημών / Department of Biological Sciences
dc.type.uhtypeArticleen
dc.description.notes<p>Cited By :18</p>en
dc.source.abbreviationAIDS Res.Hum.Retrovirusesen
dc.contributor.orcidKostrikis, Leontios G. [0000-0002-5340-7109]
dc.gnosis.orcid0000-0002-5340-7109


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record